Cardiac Assessment Before TIPSS: Frontline Gastroenterology | August 2026

Introduction:

Transjugular intrahepatic portosystemic shunt (TIPSS) is highly effective for portal hypertensive complications, but the sudden increase in venous return can precipitate cardiac decompensation, particularly in patients with cirrhotic cardiomyopathy or occult heart disease. This review examines how best to assess cardiac risk before TIPSS and manage patients after the procedure.

Why was this review needed?

Cardiac decompensation after TIPSS is clinically important and not uncommon.

Cirrhotic cardiomyopathy may remain silent until the haemodynamic stress of TIPSS.

Current screening strategies vary widely between centres.

There is no universally accepted threshold for NT-proBNP, echocardiographic parameters, or further cardiac testing.

Key Takeaways:

Pre-TIPSS assessment should combine clinical evaluation, ECG, NT-proBNP and echocardiography rather than relying on a single test.

Echocardiography should assess both systolic and diastolic function, right-sided pressures, valvular disease and features of pulmonary hypertension.

Abnormal biomarkers or echocardiographic findings should prompt more detailed cardiology assessment before elective TIPSS.

Patients at increased cardiac risk require careful post-TIPSS volume management and surveillance for heart failure, particularly during the early period after shunt creation.

Updated concepts of cirrhotic cardiomyopathy should increasingly inform patient selection and risk stratification.

Clinical Impact:

The success of TIPSS depends not only on portal decompression but also on the heart's ability to tolerate the resulting circulatory load. A structured cardiac work-up can help identify patients who may require optimization, additional testing, or reconsideration of TIPSS before the procedure.

Bottom Line:

Cardiac screening should be an integral part of elective TIPSS assessment. Combining NT-proBNP with comprehensive echocardiography and targeted cardiology evaluation can identify patients at risk of post-TIPSS heart failure and improve procedural selection and follow-up.